If the defendant does not pay the above fine, KRW 100,000.

1. No person other than a pharmacy founder who has violated the Pharmaceutical Affairs Act due to sale of fake, etc. shall sell or acquire drugs for the purpose of sale;

Nevertheless, the Defendant, in collusion with the “C” et al., sold approximately 300,00 won on the Internet homepage to an unspecified purchaser who wishes to report on the Internet website advertisements, etc., including “Igra,” “Igra,” “Igra,” “Igra,” etc., a fake drug containing functionally handicapped ingredients, which is a raw material for treating functional disorders containing pre-dive medicine ingredients, from around November 2012 to May 9, 2013.

2. No person who violates the Pharmaceutical Affairs Act due to storage of fake, etc. shall store drugs manufactured for the purpose of sale without obtaining permission from the Minister of Food and Drug Safety or filing a report on manufactured items with the Minister of Food and Drug Safety.

Nevertheless, around June 4, 2013, the Defendant indicated the following as follows: (a) around June 4, 2013, the Defendant’s application for changes in indictment in the form of a fake 100mgrogra 100mg (90 g), 2 100mg g 100m g 100m g 100m g g 100m g g 100 g g 2 g g 2 g g 1000 g g 200 g g 200 g g 200 g g g 200 g g g nb nb nb nb nb nb nb nb nb nb nb nb nb nb n

B stored for each sale purpose.

Summary of Evidence

1. The defendant's legal statement (the third trial date);

1. Each prosecutor's interrogation protocol concerning E and F;

1. Each police suspect interrogation protocol concerning E and F;

1. The police statement concerning G;

1. Police seizure records;

1. Application of Acts and subordinate statutes to internal investigation reports (Internet data attachment), investigation reports (E operational donation treatment chemicals sales site outputs);

1. Article 93 (1) of the Pharmaceutical Affairs Act concerning criminal facts and the choice of punishment;